This site is intended for healthcare professionals only

Diabetes &
Primary Care

Issue:

Share this article

How to use GLP-1 receptor agonist therapy safely and effectively

Nicola Milne

Publisher’s note: This article is now out of date. An updated version can be found here.

Save, Share, Print Article

Share this article

Clinical guidance, Newer therapies, Type 2 diabetes

Latest articles

Diabetes Distilled: Time to intensify blood pressure treatment in people with type 2 diabetes?

How to undertake a multiple long-term conditions review

Diabetes Distilled: Preserving muscle is important when using incretin mimetics for weight loss

At a glance factsheet: Diabetes and cancer

Editorial: Weight loss drug hype grows

PCDS is evolving: Introducing the Primary Care Diabetes & Obesity Society

Prescribing pearls: A guide to SGLT2 inhibitors

Related content

Diabetes Distilled: Time to intensify blood pressure treatment in people with type 2 diabetes?

BPROAD study: Reducing systolic blood pressure to <120 mmHg versus <140 mmHg in people with type 2 diabetes reduces cardiovascular events.

How to undertake a multiple long-term conditions review

Delivery of holistic care to adults living with type 2 diabetes and one or more additional long-term condition.

Diabetes Distilled: Preserving muscle is important when using incretin mimetics for weight loss

How to minimise loss of muscle mass when using GLP-1-based therapies for weight loss.

At a glance factsheet: Diabetes and cancer

The potential links between diabetes and cancer, plus practical recommendations on management of hyperglycaemia in patients undergoing cancer treatment.

For the latest news and articles

Sign up to all DiabetesontheNet journals

Follow us for all the latest news and updates in diabetes.

Resources

Journals

Useful information

© Copyright Omniamed Communications. All Rights Reserved
108 Cannon Street, London, EC4N 6EU. Registered in the United Kingdom

;